{"id":162526,"date":"2026-09-07T13:03:40","date_gmt":"2026-09-07T13:03:40","guid":{"rendered":"https:\/\/flamenet.io\/2026\/09\/07\/linvoseltamab-improves-health-related-quality-of-life-in-relapsed-refractory-multiple-myeloma-onclive-2\/"},"modified":"2026-09-07T13:03:40","modified_gmt":"2026-09-07T13:03:40","slug":"linvoseltamab-improves-health-related-quality-of-life-in-relapsed-refractory-multiple-myeloma-onclive-2","status":"publish","type":"post","link":"https:\/\/flamenet.io\/2026\/09\/07\/linvoseltamab-improves-health-related-quality-of-life-in-relapsed-refractory-multiple-myeloma-onclive-2\/","title":{"rendered":"Linvoseltamab Improves Health-Related Quality of Life in Relapsed\/Refractory Multiple Myeloma &#8211; OncLive"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMivwFBVV95cUxPcGFIYzJpVWZMSlYxOWphVFNobThjd25fdWdqOXA3RkRIYWIyYTZNT1lYck51aUFHQnoybHR0bVA2RTMzZFdpN05CODVVd3JXcG5iV19qblQ1UkQ0VFBBLUNvZDVPTEJnNUpHRUVVNFhqTTZJdWYwekJQT0xVeEk0VE9OcXR1TjB4eHhMeFF6aUVBaEdQbXhPTDRpeVlVQ1lTUGhRODIzSmx3Sm51bnA3T2JrUlByd05rcGdDeWpGaw?oc=5\" target=\"_blank\">Linvoseltamab Improves Health-Related Quality of Life in Relapsed\/Refractory Multiple Myeloma<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">OncLive<\/font><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Linvoseltamab Improves Health-Related Quality of Life in Relapsed\/Refractory Multiple Myeloma&nbsp;&nbsp;OncLive<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[61],"tags":[],"class_list":["post-162526","post","type-post","status-publish","format-standard","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/162526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/comments?post=162526"}],"version-history":[{"count":0,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/posts\/162526\/revisions"}],"wp:attachment":[{"href":"https:\/\/flamenet.io\/api\/wp\/v2\/media?parent=162526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/categories?post=162526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flamenet.io\/api\/wp\/v2\/tags?post=162526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}